Rosetta Genomics Posts Q4 Revenues Following Product Launches

Rosetta Genomics today reported fourth-quarter revenues of $119,000 compared to no revenues for the fourth quarter of 2008. The Israel-based microRNA molecular diagnostics maker launched its first three tests late in 2009 — the miRview mets, miRview meso and miRview squamous tests. Read More